²é¿´: 1411  |  »Ø¸´: 8
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

angelhunte

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

²ËÄñ

[ÇóÖú] »ÔÈðÐÂÉÏÊеÄÐÂÒ©crizotinibµÄALKøÒÖÖÆÂÊÊǶàÉÙ£¬Èç¹ûÓÐÎÄÏ×»á×·¼Ó100½ð±Ò

»ÔÈðÐÂÉÏÊеÄÐÂÒ©crizotinibµÄALKøÒÖÖÆÂÊÊǶàÉÙ£¬Èç¹ûÓÐÎÄÏ×»á×·¼Ó100½ð±Ò
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

Çó¹¤×÷
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

С¶¬¹ÏÝæÝæ

Òø³æ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
angelhunte: ½ð±Ò+12, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2012-09-19 09:06:56
angelhunte: »ØÌûÖö¥ 2012-09-19 09:07:00
³ÕÒÄ×ÓÆ¤: ½ð±Ò+1, лл½»Á÷£¬»¶Ó­³£À´Å¶¡£ 2012-09-20 08:33:37
ʵÔÚ²»ÐУ¬¾ÍÖ±½ÓÎÊÎÊJean Cui£¬¹þ¹þ£¬Ëý¿Ï¶¨×îÇå³þ£¬ÕâÒ©¾ÍÊÇËý×öµÄ¡£ÓÊÏäjean.cui@pfizer.com.
7Â¥2012-09-19 09:04:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 9 ¸ö»Ø´ð

songxiangen

½ð³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
³ÕÒÄ×ÓÆ¤: ½ð±Ò+1, лл½»Á÷£¬»¶Ó­³£À´Å¶¡£ 2012-09-20 08:32:53
Crizotinib (PF-02341066) µÄÉúÎï»îÐÔ
Inhibitor of the catalytic activity of c-Met kinase and the NPM-ALK(nucleophosmin-anaplastic lymphoma kinase) fusion protein.[1] A t(2;5) chromosomal translocation resulting in expression of an oncogenic kinase fusion protein known as NPM-ALK has been implicated in the pathogenesis of anaplastic large-cell lymphoma (ALCL). [2]
After incubation with Crizotinib (PF-02341066), cells were washed once with HBSS supplemented with 1 mmol/L Na3VO4 and protein lysates were generated. Subsequently, phosphorylation of ALK was assessed by a sandwich ELISA method using an immobilized anti¨Ctotal-ALK antibody and an anti¨Cphospho-ALK antibody (pY1604) as a detec ion antibody.
Crizotinib (PF-02341066) inhibited NPM-ALKphosphorylation in Karpas299 or SU-DHL-1 ALCL cells (mean IC50 value=24 nM).
Crizotinib (PF-02341066) potently inhibited cell proliferation, which was associated with G1-S¨Cphase cell cycle arrest and induction of apoptosis in ALK-positive ALCL cells (IC50 values=30 nM) but not ALK-negative lymphoma cells. The induction of apoptosis was confirmed using terminal deoxyribonucleotide transferase¨Cmediated nick-end labeling and Annexin V staining (IC50 values=25¨C50 nM). [3]

Crizotinib (PF-02341066) ²Î¿¼ÎÄÏ×
[1] Blood 2005;105: 2640-2653
[2] Oncogene 2001;20:5623-5637
[3] Mol Cancer Ther 2007;6:3314-3322

²»ÖªµÀ¶ÔÂ¥Ö÷ÓÐûÓÐÓÃ
2Â¥2012-09-18 11:35:33
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

angelhunte

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

²ËÄñ

ÒýÓûØÌû:
2Â¥: Originally posted by songxiangen at 2012-09-18 11:35:33
Crizotinib (PF-02341066) µÄÉúÎï»îÐÔ
Inhibitor of the catalytic activity of c-Met kinase and the NPM-ALK(nucleophosmin-anaplastic lymphoma kinase) fusion protein. A t(2;5) chromosomal translocation r ...

ϸ°û»îÐÔ£¬ÎÒÒªµÄÊÇø»îÐÔ£¬Óб¨µÀ˵СÓÚ1nM,µ«²»ÖªµÀ¾ßÌåÊý¾Ý
Çó¹¤×÷
3Â¥2012-09-18 15:02:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

С¶¬¹ÏÝæÝæ

Òø³æ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
angelhunte: ½ð±Ò+8, ¡ïÓаïÖú, ÖÁÉÙ˵Ã÷ÄúÈÏÕæ¿´¹ý 2012-09-18 22:37:21
³ÕÒÄ×ÓÆ¤: ½ð±Ò+2, лл½»Á÷£¬»¶Ó­³£À´Å¶¡£ 2012-09-20 08:32:59
»¹ÊÇÎÒÀ´Ó¦´ð°É£¡
crizotinibµÄALKøÒÖÖÆÂÊ99%£¨1΢Ħ¶ûŨ¶ÈÏ£©£¬ALKøÒÖÖÆIC50СÓÚ1nm¡£
²Î¿¼ÎÄÏ×£ºJournal of Medicinal chemistry 2011£¬ 54£¬ 6342-6363£¨Table¡£5.£©
4Â¥2012-09-18 16:41:24
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 313Çóµ÷¼Á +3 ËÁÈþ·¡Ò¼22 2026-03-19 3/150 2026-03-21 08:01 by JourneyLucky
[¿¼ÑÐ] »úеר˶299Çóµ÷¼ÁÖÁ²ÄÁÏ +3 kkcoco25 2026-03-16 4/200 2026-03-21 03:52 by JourneyLucky
[¿¼ÑÐ] ²ÄÁϹ¤³Ì£¨×¨£©Ò»Ö¾Ô¸985 ³õÊÔ335Çóµ÷¼Á +3 hiloiy 2026-03-17 4/200 2026-03-21 03:04 by JourneyLucky
[¿¼ÑÐ] ³õʼ318·ÖÇóµ÷¼Á£¨Óй¤×÷¾­Ñ飩 +3 1911236844 2026-03-17 3/150 2026-03-21 02:33 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖпƼ¼´óѧ£¬080502£¬354·ÖÇóµ÷¼Á +5 ÊØºòϦÑôCF 2026-03-18 5/250 2026-03-21 01:06 by JourneyLucky
[¿¼ÑÐ] 22408 344·Ö Çóµ÷¼Á Ò»Ö¾Ô¸ »ªµç¼ÆËã»ú¼¼Êõ +4 solanXXX 2026-03-20 4/200 2026-03-20 23:49 by alg094825
[¿¼ÑÐ] Ò»Ö¾Ô¸Äϲý´óѧ£¬327·Ö£¬²ÄÁÏÓ뻯¹¤085600 +9 Ncdx123456 2026-03-19 9/450 2026-03-20 23:41 by lovewei0727
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤ 322Çóµ÷¼Á +4 È»11 2026-03-19 4/200 2026-03-20 22:12 by luoyongfeng
[¿¼ÑÐ] 290Çóµ÷¼Á +7 ^O^Ø¿ 2026-03-19 7/350 2026-03-20 21:43 by JourneyLucky
[¿¼ÑÐ] ²ÄÁÏѧ˶297ÒѹýËÄÁù¼¶Çóµ÷¼ÁÍÆ¼ö +11 adaie 2026-03-19 11/550 2026-03-20 21:30 by laoshidan
[¿¼ÑÐ] ²ÄÁÏѧÇóµ÷¼Á +4 Stella_Yao 2026-03-20 4/200 2026-03-20 20:28 by ms629
[¿¼ÑÐ] 281Çóµ÷¼Á£¨0805£© +14 ÑÌÏ«Ò亣 2026-03-16 25/1250 2026-03-20 15:47 by yuncha
[¿¼ÑÐ] Ò»Ö¾Ô¸¸£´ó288Óлú»¯Ñ§£¬Çóµ÷¼Á +3 Сľ³æ200408204 2026-03-18 3/150 2026-03-19 13:31 by houyaoxu
[¿¼ÑÐ] ²ÄÁÏ¿¼Ñе÷¼Á +3 xwt¡£ 2026-03-19 3/150 2026-03-19 11:22 by wãåÑôw
[¿¼ÑÐ] ¡¾Í¬¼ÃÈí¼þ¡¿Èí¼þ£¨085405£©¿¼ÑÐÇóµ÷¼Á +3 2026eternal 2026-03-18 3/150 2026-03-18 19:09 by ²«»÷518
[¿¼ÑÐ] 085601ר˶£¬×Ü·Ö342Çóµ÷¼Á£¬µØÇø²»ÏÞ +5 share_joy 2026-03-16 5/250 2026-03-18 14:48 by haxia
[¿¼ÑÐ] ÉúÎïѧ071000 329·ÖÇóµ÷¼Á +3 ÎÒ°®ÉúÎïÉúÎﰮΠ2026-03-17 3/150 2026-03-18 10:12 by macy2011
[¿¼ÑÐ] 293Çóµ÷¼Á +11 zjlµÄºÅ 2026-03-16 16/800 2026-03-18 08:10 by zhukairuo
[¿¼ÑÐ] 327Çóµ÷¼Á +6 ʰ¹âÈÎȾ 2026-03-15 11/550 2026-03-15 22:47 by ʰ¹âÈÎȾ
[¿¼ÑÐ] ±¾¿ÆÄϾ©´óѧһ־Ը´¨´óҩѧ327 +3 ÂóÌï¸ûÕß 2026-03-14 3/150 2026-03-14 20:04 by ÍâÐÇÎÄÃ÷
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û